Better together: integrating moud in african american community settings. September 15, 2023 to january 31, 2026. N01DA-22-2253. Task order 75N95023F00004 (TO8).
Active Awarded Last action
- Contract number
- 75N95023F00004
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $999,995
Award facts
- Contract value 100% obligated
- $999,995.00 Current and potential, with all options
- Completion date 92% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $999,995 |
About this award
The National Institute on Drug Abuse issued a delivery order to The Emmes Company, LLC on September 15, 2023, with a ceiling value of $999,995, under the NIDA Data, Statistics, and Clinical Trial Support Center IDV (N01DA-22-2253) for the "Better Together: Integrating MOUD in African American Community Settings" research initiative.
The parent IDV, valued at $44.3 million with ceiling through September 4, 2027, supports substance abuse treatment trials including studies on opioid use disorder, medication-assisted treatment interventions, and the HEAL initiative. Place of performance is Rockville, Maryland. The delivery order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of January 31, 2027. No set-aside was used.
SCI-reported activity shows FY2024 invoicing of $115 thousand (0.5 FTEs, 1,069 contractor hours at $107.38 per hour) and FY2025 invoicing of $482 thousand (1.7 FTEs). The prime self-performed all reported hours with no subcontractor engagement in both fiscal years.
Quick answers
Who was awarded contract 75N95023F00004?
75N95023F00004 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 15, 2023.
How much is contract 75N95023F00004 worth?
The government has obligated $999,995 on 75N95023F00004.
Is contract 75N95023F00004 an order under another contract?
Yes. 75N95023F00004 is a delivery order under 75N95022D00017, an indefinite delivery contract.
Was contract 75N95023F00004 competed?
The extent of competition for 75N95023F00004 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award